Stran & Company Reports $33.4 Million in Revenue and $0.6 Million in EBITDA for the Second Quarter of 2026

Stran & Company, Inc. (SWAG) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Stran & Company Reports $33.4 Million in Revenue and $0.6 Million in EBITDA for the Second Quarter of 2026 Conference Call to be Held Wednesday, August 12, 2026 at 10:00 a.m. Eastern Time Quincy, MA / August 11, 2026 / Stran & Company, Inc. (“Stran” or the “Company”)

Original reporting
Published Aug 11, 2026, 8:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 11, 2026, 8:32 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$SWAG
Bullish
medium confidence
Mentioned
$SWAG
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$SWAGBullishMed
01

Why it matters

The disclosure updates investors on profitability (gross profit, EBITDA), segment trends (Stran vs SLS), and capital allocation (repurchase activity), setting expectations for the Aug 12 call.

02

Market read

Fresh quarterly and year-to-date financials plus a stated new contract and resumed share repurchases create a tradable catalyst ahead of the scheduled conference call.

03

What to watch

Traders may overemphasize first-half strength; the key swing factor is whether SLS gross margin expansion and operating income durability persist beyond order timing effects.

Relevance 7/10Novelty 7/10Timing: after-hours filing today, conference call scheduled Aug 12 at 10:00 a.m. ET

Background

This is an SEC 8-K (Item 2.02) with Exhibit 99.1 press release covering Stran’s Q2 and first-half 2026 financial results and business update.

Company-level read

Ticker impact

$SWAGBullishMedium confidence
Context

Stran reported Q2 2026 results with $33.4M revenue (+2.4% YoY) and $0.6M EBITDA, plus a new enterprise contract and resumed buybacks.

Expected impact

Moderate positive bias into/after the Aug 12 conference call, with focus on margin trajectory and whether SLS variability stabilizes.

Evidence & confidence

Revenue and gross profit rose in both quarter and first-half, EBITDA improved, and management highlighted a new contract and resumed repurchases; however, net income and EBITDA for the quarter are modest and SLS revenue timing variability remains a caveat.

Market effects

Adds datapoint on outsourced marketing/promotional products demand and profitability leverage, but no direct sector-wide catalyst is disclosed.

No specific regional macro or supply-chain shock is mentioned.

Primarily company-specific; no international regulatory or macro linkage is provided.

Counterpoint

Quarterly EBITDA declined versus the prior-year quarter ($0.6M vs $0.9M), and SLS revenue timing variability could mask weaker underlying demand.

Key entities

  • Stran & Company, Inc.

    Outsourced marketing solutions provider reporting Q2 and first-half 2026 results and business update in an 8-K.

  • Stran Loyalty Solutions, LLC (SLS)

    Segment highlighted for improving gross profit and operating income, with noted revenue timing variability.

  • Andy Shape

    CEO quoted on first-half performance and business progress.

Related articles

$SWAGMed

Stran & Company Reports 32% Increase in Third Quarter 2026 Gross Profit as Gross Margin Expands to 33.3%

Stran & Company, Inc. (SWAG) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Stran & Company Reports 32% Increase in Third Quarter 2026 Gross Profit as Gross Margin Expands to 33.3% Nine-Month Net Income of $1.1 Million, an Improvement of $2.1 Million Over the Prior-Year Period Conference Call to be Held Wednesday, November 11, 2026 at 10:00

$SWAGMed

Stran (SWAG) Q2 2026 Earnings Call Transcript

Stran (SWAG) reported Q2 2026 revenue of $33.4M, up 2.4% YoY. Stran segment revenue grew 6.9% YoY, while SLS segment revenue declined 6.5%. Gross profit increased 1.6% to $10.0M, with gross margin at 30.0%. Net income was $309K, down from $643K YoY. The company secured new contracts and improved SLS gross margin to 24.3%. Management expects public warrant expiration in Q4 2026.

$GOSSMed

Gossamer Bio Announces Third Quarter 2026 Financial Results and Provides Business Update

Gossamer Bio, Inc. (GOSS) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Gossamer Bio Announces Third Quarter 2026 Financial Results and Provides Business Update – New Drug Application for Seralutinib in PAH Submitted to the U.S. FDA in September 2026 – – Structured Private Placement Provides $25 Million Upfront and Up to $125 Million of

$GSLHighAI 8/10

Global Ship Lease, Inc. (GSL): Financial results for Q3 2026

Global Ship Lease, Inc. (GSL) furnished an SEC Form 6-K — earnings release. Exhibit 99.1 Investor and Media Contacts: IGB Group Bryan Degnan 646-673-9701 or Leon Berman 212-477-8438 Global Ship Lease Reports Results for the Third Quarter of 2026 Annualized dividend to increase to $2.75 per Class A Common Share Further de-risked our newbuilding program wi

$AZTAMedAI 8/10

Azenta Reports Fourth Quarter and Full Year Results for Fiscal 2026, Ended September 30, 2026

Azenta, Inc. (AZTA) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Azenta Reports Fourth Quarter and Full Year Results for Fiscal 2026, Ended September 30, 2026. • Q4'26 reported revenue growth of 5% year over year and 2% on an organic basis • FY'26 reported revenue growth of 5% year over year and 2% on an organic basis • FY'27 repo